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of the prenatal environment, robust associations are found between 
reduced birth weight and increased risk of later disease in numerous 
populations worldwide (Whincup et al., 2008). Furthermore, these 
associations are continuous across a wide range of normal birth 
weights, and act largely independently of other lifestyle factors such 
as socioeconomic status and current obesity (Barker, 2004).
Two major hypotheses have been proposed to underlie these 
associations between adverse prenatal conditions and postnatal 
health – fetal malnutrition (Barker et al., 1993) and overexposure 
to glucocorticoids (Edwards et al., 1993; Seckl, 2004). Importantly, 
these hypotheses are not mutually exclusive. Alterations in maternal 
nutrition or placental dysfunction, which result in reduced nutri-
ent delivery to the fetus, also affect fetal glucocorticoid exposure. 
Conversely, antenatal stress or maternal administration of gluco-
corticoids affects feeding behaviour. Given their potent actions dur-
ing development, excess glucocorticoids likely represent a common 
pathway by which poor environmental conditions are signalled 
from the mother to the fetus, triggering changes in offspring growth 
and permanently affecting tissue and organ function.
GLUCOCORTICOIDS AS MEDIATORS OF DEVELOPMENTAL 
PROGRAMMING
Glucocorticoids, steroid hormones produced predominantly by the 
adrenal gland, are key mediators of stress responses. Whilst the 
acute and chronic effects of pharmacological glucocorticoid excess 
are well-recognised (including induction of hyperglycemia, insu-
lin resistance, hyperlipidemia, hypertension and dysphoria, with 
suppression of immune, infl ammatory and cognitive processes), 
INTRODUCTION
It is now widely recognized that exposure to an adverse environ-
ment during prenatal development can have lasting effects on an 
individual’s physiology and risk of disease. Maternal malnutri-
tion, psychological stress or perturbed hormonal status (e.g. glu-
cocorticoid overexposure or the hyperinsulinemia associated with 
gestational diabetes) transmit signals to the developing fetus and, 
depending on the timing of these exposures, permanently affect tis-
sue structure and function. Although fetal responses to such expo-
sures may impart an enhanced capacity to cope with the immediate 
stressor, such in utero ‘developmental programming’ can contribute 
a signifi cant risk for a number of important adult diseases. For 
instance, adaptations to an intrauterine environment in which oxy-
gen and nutrients may be limited has been suggested to promote 
the development of a ‘thrifty phenotype’, reducing fetal growth and 
favouring metabolic effi ciency (Hales and Barker, 1992).
In terms of developmental metabolic programming, numerous 
studies in both humans and animal models have shown that a poor 
intrauterine environment followed by postnatal overnutrition pro-
motes the development of diseases including hypertension, insulin 
resistance, central obesity and type 2 diabetes (Gluckman et al., 
2005). Maternal stress during pregnancy is also associated with 
intrauterine growth restriction (IUGR) and an increased risk of 
premature birth (Rondo et al., 2003), as well as with emotional and 
cognitive defi cits in early life (Talge et al., 2007). Thus, low birth 
weight as an indicator of a suboptimal intrauterine environment 
has been used extensively as a predictor of later disease risk (Barker 
et al., 1993). Although low birth weight is a relatively crude marker 
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their role in the biology of the response to stress is more nuanced, 
with balanced homeostatic effects to facilitate short-term survival 
and recovery from challenge (Munck and Naray-Fejes-Toth, 1994; 
McEwen, 2007). In addition, glucocorticoids are crucial during fetal 
development for the maturation of tissues and organs, promoting 
cellular differentiation, and most notably acting during late gesta-
tion to stimulate surfactant production by the lung. This action is 
critical to prepare the fetus for extrauterine life, and it is for this 
reason that synthetic glucocorticoid treatment is so widely used 
in preterm pregnancies where lung immaturity threatens neona-
tal viability. Although these treatments greatly improve survival 
(Roberts and Dalziel, 2006), they are not without adverse affects.
Numerous studies across a wide range of species have shown 
that prenatal treatment with glucocorticoids reduces birth weight 
and that these offspring are at increased risk of cardio-metabolic 
disease, hypothalamic–pituitary–adrenal (HPA) axis perturba-
tions and affective disorders in later life (Seckl, 2004). Moreover, 
in human pregnancies complicated by intrauterine growth restric-
tion (IUGR), fetal cortisol levels are elevated at term (Goland et al., 
1993), associating reduced fetal growth rates with elevated gluco-
corticoids. The effects of exogenous glucocorticoids on birth weight 
are greatest when administered during periods of rapid growth, 
typically the later stages of pregnancy (Nyirenda et al., 1998). It 
has been shown in rats that excess maternal glucocorticoids are 
key in mediating the effects of maternal stress or diet on offspring 
hypertension (Langley-Evans, 1997a; Lesage et al., 2001). Inhibition 
of maternal glucocorticoid synthesis using metyrapone in pregnant 
rats prevents the increased blood pressure seen in offspring of low 
protein diet fed rat dams. Replacement of corticosterone to the dam 
reinstated the programming effects, interestingly only in female 
offspring (Langley-Evans, 1997a). Maternal adrenalectomy likewise 
prevented the reduction in fetal adrenal weights seen with mater-
nal food restriction, however fetal body weights were still lower in 
adrenalectomised and food-restricted fetuses (Lesage et al., 2001). 
These studies lend support to the idea that maternal glucocorti-
coids mediate at least a component of the programming effects on 
offspring HPA axis perturbations on fetal development.
A number of the adult diseases associated with the ‘low birth 
weight baby syndrome’ involve perturbations in key  glucocorticoid-
responsive tissues, notably liver, adipose tissue and brain. As described 
below, a re-setting of HPA axis sensitivity is thought to underlie 
many of the cardio-metabolic outcomes associated with low birth 
weight and glucocorticoid overexposure. Furthermore, many of the 
affective disorders that are linked to prenatal stress involve glucocor-
ticoid-sensitive central nervous system (CNS) targets. Excess gluco-
corticoid exposure in late pregnancy can also induce long-lasting 
effects on peripheral tissue expression of  glucocorticoid-sensitive 
genes. In rat models of prenatal glucocorticoid exposure or maternal 
malnutrition, the hepatic glucocorticoid receptor (GR) is upregu-
lated, plausibly driving the observed increase in both the expression 
and activity of the gluconeogenic enzyme phosphoenolypyruvate 
carboyxkinase (PEPCK), and programming insulin resistance and 
impaired glucose tolerance in adult life (Hales et al., 1996; Ozanne 
et al., 1996; Nyirenda et al., 1998).
It is clear that the effects of prenatal stress and glucocorti-
coid excess during pregnancy on subsequent physiological and 
 psychological outcomes differ not only due to the timing of 
 exposure, but also on the sex of the offspring. In human pregnancy, 
the placenta of female fetuses may impart a relative protection from 
glucocorticoid excess due to increased glucocorticoid inactivation 
(discussed in more detail below) compared with males (Clifton and 
Murphy, 2004). Recent data in the rat has also shown that male, 
but not female, offspring exposed to stress in early gestation exhib-
ited increased anxiety-related behaviours as adults, again changes 
associated with sex-differences in placental function (Mueller and 
Bale, 2008). However, the precise mechanisms of sex-specifi c sus-
ceptibility to prenatal insults is not yet clear. Likewise, the issue 
of timing is clearly species specifi c, and presumably related to the 
expression of GR and mineralocorticoid receptors (MR) in relation 
to the exposure. These issues are reviewed in more detail elsewhere 
(Matthews et al., 2002; Kapoor et al., 2008, 2009).
MOLECULAR MEDIATORS OF EARLY LIFE STRESS
PLACENTAL 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 2
In normal pregnancy, maternal glucocorticoid levels are mark-
edly higher than those in the fetal circulation. The fetus is pro-
tected from the relatively high maternal glucocorticoid levels of 
pregnancy by the placental inactivation of active glucocorticoids 
(cortisol in humans, corticosterone in rodents) to its inactive 11-
keto forms (cortisone and 11-dehydrocorticosterone, respectively) 
by the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-
HSD2). This enzyme acts as a ‘barrier’ to prevent premature or 
inappropriate action at glucocorticoid-responsive tissues during 
fetal development.
It has been suggested that a reduction in the expression or 
activity of placental 11β-HSD2, by leading to increased trans-
placental passage of active glucocorticoids, reduces fetal growth. 
In support of this notion, in human and rodent pregnancy fetal 
weight is correlated with 11β-HSD2 activity (Stewart et al., 1995; 
Lindsay et al., 1996; Murphy et al., 2002). In addition, mutations 
in the HSD11B2 gene in humans, although rare, markedly reduce 
birth weight (Dave-Sharma et al., 1998). Numerous studies have 
shown that inhibition of 11β-HSD2 during pregnancy leads to a 
reduction in birth weight and the development of later hyperten-
sion and glucose intolerance (Edwards et al., 1993; Lindsay et al., 
1996; Langley-Evans, 1997b), as well as programming increased 
HPA axis activity and anxiety-related behaviours (Welberg et al., 
2000). More recently, genetic manipulations have shown that 
11β-HSD2 knockout mice (11β-HSD2−/−) exhibit reduced birth 
weight and heightened anxiety in adulthood (Holmes et al., 2006). 
Moreover, heterozygous matings of 11β-HSD2+/− animals have 
shown that allelic defi ciency in fetal 11β-HSD2 and birth weight 
follow a dose–response pattern. Within the same litter from hetero-
zygous crosses, homozygous knockout offspring (11β-HSD2−/−) 
are signifi cantly lighter than wildtype littermates (11β-HSD2+/+), 
with heterozygotes intermediate, suggesting sensitive gene dosage 
effects (Holmes et al., 2006; Wyrwoll et al., 2009). Studies using 
this model have recently shown that placental transport function, 
clearly important in the determination of fetal growth and off-
spring birth weight, is impaired in late gestation in 11β-HSD2−/− 
fetuses (Wyrwoll et al., 2009). It is not yet clear whether excess 
fetal glucocorticoids down-regulate placental function per se and 
thus reduce fetal growth, although one study in rats has suggested 
that reduced placental weight and glucose transport in response to 
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maternal low protein diet precedes any signifi cant reduction in fetal 
weight, suggesting that reduced nutrient transport is causal in IUGR 
(Jansson et al., 2006). Alternatively, it may be that in response to 
fetal growth restriction (due to maternal malnutrition or elevated 
fetal glucocorticoids secondary to reduced placental 11β-HSD2), 
the placenta is able to up-regulate transport function and increase 
its effi ciency as a compensatory mechanism to a point, but that this 
is insuffi cient to sustain normal fetal growth during the last stages 
of pregnancy when growth is most rapid.
Interestingly, it appears that there are gene-interaction effects 
on 11β-HSD2 function. Initial studies investigating the effects of a 
complete lack of 11β-HSD2 reported that although there was clearly 
an effect on blood pressure resulting from a lack of this gene, that 
fetal weight was unaltered (Kotelevtsev et al., 1999). This has been 
suggested to be due perhaps to the crossed background used in this 
mouse model, compared with that of the more recent 11β-HSD2 
transgenic models mentioned above which are maintained on the 
C57/Bl6 background (Seckl and Meaney, 2006). More recently, a 
study using rats selectively bred to exhibit high or low levels of 
anxiety behaviour (HAB and LAB rats respectively) revealed that 
in response to repeated maternal stress throughout pregnancy, 11β-
HSD2 activity was reduced only in the placentas of HAB offspring 
(Lucassen et al., 2009). This segregation of behavioural traits in 
association with differences in molecular responses of a known glu-
cocorticoid programming related gene are intriguing, however the 
identity of potential modifying genes are at present unknown.
Importantly, placental 11β-HSD2 may be a crucial node between 
the maternal environment and the fetus. Thus, maternal undernu-
trition or ingestion of a low protein diet (which also lower birth 
weight and leads to cardio-metabolic syndrome in the offspring) 
decreases the expression and/or activity of placental 11β-HSD2 
(Langley-Evans et al., 1996; Lesage et al., 2001; Stocker et al., 2004). 
Maternal stress similarly reduces placental 11β-HSD2 (Mairesse 
et al., 2007). In vitro studies using placental cells lines have also 
indicated that a number of other factors, including hypoxia, cat-
echolamines and proinfl ammatory cytokines, can down-regulate 
11β-HSD2 activity (Hardy and Yang, 2002; Chisaka et al., 2005; 
Homan et al., 2006). These fi ndings are of particular relevance to 
human situations of placental insuffi ciency or maternal infection. 
A proposed model for fetal programming by altered placental func-
tion and/or glucocorticoid overexposure is indicated in Figure 1.
GLUCOCORTICOID RECEPTOR
During development, GRs are expressed from early embryonic life 
in most tissues. Glucocorticoid receptors are essential for offspring 
survival, as indicated by the lethal postnatal phenotype of GR null 
mice (Cole et al., 1995). The use of transgenic mouse models has 
identifi ed that variation in the level of GR alters stress responses 
and activity of the HPA axis. A 30–50% reduction in GR is associ-
ated with exaggerated HPA responses to stress (Pepin et al., 1992; 
Michailidou et al., 2008), whereas the generation of transgenic 
GR-overexpressing animals produces mice with a relatively stress-
 resistant phenotype (Reichardt et al., 2000; Wei et al., 2004).
Exposure of the fetus to stress or high levels of glucocorticoids – 
whether from exogenous or endogenous origins – can permanently 
affect GR expression. For instance, inhibition or defi ciency of 
placental 11β-HSD2 has been shown to reduce hippocampal GR 
expression (Levitt et al., 1996) but conversely increases amygdala 
GR mRNA levels (Welberg et al., 2000). A reduction in hippoc-
ampal GR would be expected to reduce glucocorticoid negative 
feedback and lead to an overactive HPA axis. In contrast, increased 
GR expression in the amygdala, a key CNS structure involved in 
mediating fear and anxiety responses, associates with an anxiogenic 
phenotype in rodents (Welberg et al., 2000).
Although present in almost all cells, there is considerable varia-
tion in GR expression between different tissues and, in the case of the 
CNS, even between different brain nuclei (Herman et al., 1989). The 
receptor protein itself is encoded by exons 2–9, however the com-
plexity of such tissue-specifi c regulation is conferred by the presence 
of multiple alternative untranslated fi rst exons (McCormick et al., 
2000; Turner and Muller, 2005). There is currently extensive evi-
dence that at least a component of the programming effects induced 
by early life events involves alterations in expression of specifi c 
FIGURE 1 | Overview of developmental programming. A perturbed maternal 
environment, due to poor diet, excessive stress or impaired health during 
pregnancy, impairs placental function and thus delivery of nutrients (critically 
glucose and oxygen) to the fetus. In addition, administration of exogenous 
glucocorticoids reduces the activity of placental 11β-HSD2, decreasing this 
barrier to excess glucocorticoids and reducing fetal growth. In response to these 
stressors, the developing fetus is able to adapt to the prevailing conditions in 
order to promote survival, altering tissue size, structure and function. These 
adaptations, although benefi cial in the short term, when confl icted by postnatal 
conditions predispose to an increased risk of adult disease.
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 alternative fi rst exons of GR to regulate tissue-specifi c changes in 
expression and function, at least in the brain.
In rats, exposure to high levels of postnatal care (high levels of 
licking and grooming by the dam) leads to increased GR mRNA 
expression in the hippocampus and reduced HPA axis responses 
to restraint stress as adults compared with offspring raised by low 
 licking-grooming (low-LG) dams (Liu et al., 1997). Postnatal han-
dling, which removes the differences in hippocampal GR expres-
sion, eliminates these maternal programming effects (Meaney et al., 
1989). In addition, cross-fostering studies indicate that the effect 
on GR expression is directly related to the level of maternal care 
(Francis et al., 1999). Whilst there is no difference at postnatal day 
1 (P1) in gene expression patterns between low- and high-LG off-
spring, by P6 the differences are apparent (Weaver et al., 2004). 
Thus, differences in exposure to nurturing behaviour in early life are 
suffi cient to induce long-term programming of GR expression.
This increase in GR expression is mediated by activation of 
serotonergic (5-HT) pathways in response to tactile stimulation 
(ie, handling or maternal licking/grooming; Smythe et al., 1994). 
Increased 5-HT signalling (acting via cyclic AMP-activated path-
ways) increases the expression of key transcription factors, notably 
nerve growth factor induced protein A (NGFI-A), which binds to 
and regulates activation of the GR promoter. In the hippocampus, 
NGFI-A binds promoter DNA, specifi cally within NGFI-A bind-
ing sites of exon 1
7
, increasing expression of this mRNA transcript 
(Weaver et al., 2007).
Mechanistically, differences in GR expression between the off-
spring of high- and low-LG females associate with differential 
methylation of the exon 1
7 
GR promoter (Weaver et al., 2004, 2007). 
DNA hypermethylation, along with histone hypoacetylation, are 
epigenetic modifi cations associated with relatively inactive chroma-
tin and reduced gene expression. In general, regions of the genome 
that are particularly susceptible to epigenetic modifi cation include 
gene promoter regions, regulatory regions of imprinted genes and 
transposable elements (for review, see Jirtle and Skinner, 2007). In 
low-LG offspring, the exon 1
7 
promoter is hypermethylated, histone 
H3 hypoacetylated and there is reduced binding of the activating 
transcription factor NGFI-A. Conversely, in offspring of high-LG 
mothers, the reverse situation was found, with signifi cantly lower 
levels of methylation, increased H3 acetylation and increased 
NGFI-A binding (Weaver et al., 2004).
Although epigenetic DNA modifi cations are typically thought of 
as being stable once established, pharmacological manipulation of 
acetylation and methylation patterns have been shown in low- and 
high-LG offspring. Low GR expression in the low-LG offspring can 
be reversed by the central infusion of a histone deacetylase inhibitor, 
trichostatin A (TSA), which increases acetylation of histone H3, 
reduces methylation of the exon 1
7 
region and increases NGFI-A 
binding in the adult rat brain (Weaver et al., 2004). The higher levels 
of GR in high-LG offspring can be reduced by the administration of 
the methyl donor S-adenosyl-methionine (SAM), through increased 
DNA methylation of exon 1
7 
(Weaver et al., 2005). The combined 
results of these studies imply that there is a degree of plasticity that 
remains in the adult rodent brain for alterations in gene expres-
sion by epigenetic modifi cation. Crucial appears to be transcription 
factor binding to critical DNA response elements at key sensitive 
developmental ages to maintain open chromatin for the lifespan.
Recent data from human studies have indicated that these same 
hippocampal GR targets might also be subject to programming by 
early life events. Analysis of brain tissue from suicide victims who 
were abused as children indicated a higher level of NR3C1 exon 
1
F
 methylation (the human homolog of the rat exon 1
7 
region) 
compared with non-abused suicide victims or control subjects 
(McGowan et al., 2009). These fi ndings lend further support to 
the idea that long-term stress and behavioural outcomes might be 
infl uenced by events in early life, and are consistent with previously 
reported HPA axis disturbances, induced by aversive conditions 
in childhood, on subsequent adult psychiatric health (Heim and 
Nemeroff, 2001). This mechanism, whilst intriguing, remains as yet 
to be shown in systems outside the brain. However, it is a plausible 
‘cause’ of aspects of developmental programming phenomena.
CORTICOTROPIN RELEASING HORMONE
A critical component of the central HPA axis (detailed below), 
corticotrophin releasing hormone (CRH) has also been proposed 
as a mediator of the effects of early life stress on later cognitive and 
behavioural outcomes. In humans CRH is produced by the pla-
centa and released into the maternal and fetal circulation (Goland 
et al., 1993). High concentrations of CRH are found in growth-
retarded fetuses, and elevated maternal CRH levels are associated 
with decreased gestational length and an increased risk of preterm 
delivery (Wadhwa et al., 1998). In contrast to the negative feedback 
actions of glucocorticoids on the expression and release of central 
CRH, placental production is enhanced by glucocorticoids (King 
et al., 2001). Hence, maternal stress, accompanied by elevated CRH 
and glucocorticoid concentrations, affect both the length of preg-
nancy and the hormonal environment of the developing fetus.
Administration of CRH to pregnant rat dams reduces both mater-
nal body weight during pregnancy and offspring weight during the 
fi rst two postnatal weeks, as well as enhancing offspring behavioural 
responses to a stressor in the early neonatal period (Williams et al., 
1995), effects reminiscent of the actions of maternal stress (Williams 
et al., 1998). Therefore, it was suggested that at least a component 
of stress/glucocorticoid programming effects might be mediated 
through CRH actions on the developing fetal brain.
It is perhaps noteworthy that in terms of hippocampal develop-
ment, the last trimester of human pregnancy is equated with the 
fi rst postnatal week in the rat (Avishai-Eliner et al., 2002). Although 
detailed analysis of the ontogeny of GR expression in the human 
fetal brain has not been reported, in the rat there is a relatively high 
expression of GR from midgestation onwards (Diaz et al., 1998) and 
a rapid rise in GR and MR expression after birth (Matthews et al., 
2002). Hence, the last week of gestation and early postnatal life are 
considered particularly sensitive periods in rodent development in 
terms of glucocorticoid-mediated programming.
In support of this, handling of neonatal rat pups (an inter-
vention which stimulates maternal care) reduced hypothalamic 
CRH expression and enhanced hippocampal GR expression in 
adult animals, and reduced the stress hormone responses to an 
acute stressor (Plotsky and Meaney, 1993; Avishai-Eliner et al., 
2001). Interestingly, handling induces a distinct temporal pattern 
of gene expression, with reduction in paraventricular nuclei (PVN) 
CRH expression as early as postnatal day 9 (P9) preceding the 
increase in GR (which emerged between P23–45). The same  pattern 
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of adult gene expression was shown to be induced by postnatal 
 administration of a CRH-receptor antagonist (Fenoglio et al., 2005) 
implicating this as a key molecular mechanism in the emergence 
of early life programming of the HPA axis function.
PRENATAL STRESS AND HYPOTHALAMIC–PITUITARY–
ADRENAL (HPA) AXIS PROGRAMMING
In animal models, maternal dietary restriction, antenatal gluco-
corticoid administration and prenatal stress are associated with 
elevated blood pressure and exaggerated stress responses in off-
spring, indicative of reduced negative feedback of HPA axis activity 
(Langley-Evans, 1997a; Doyle et al., 2000; de Vries et al., 2007). 
Under conditions of stress, activation of the HPA axis results in 
increased production and release of corticotrophin-releasing 
hormone (CRH) and arginine vasopressin (AVP) from the PVN. 
These hypophysiotropic hormones are released into the portal 
blood system and act on cells of the anterior pituitary to stimu-
late adrenocorticotropic hormone (ACTH) expression and release, 
which in turn increases glucocorticoid production at the adrenals. 
Subsequently, increased levels of circulating glucocorticoids feed 
back to inhibit HPA axis activity and prevent excessive produc-
tion of stress hormones. Negative feedback occurs at the level of 
the brain and at the pituitary, and in particular inhibitory inputs 
derive from hippocampal GR-expressing neurons to inhibit PVN 
neurohormone release (refer Figure 2A).
In programming models, reduced negative feedback of 
the HPA axis is thought to be due, at least in part, to a reduc-
tion in hippocampal glucocorticoid receptor (GR) signalling. 
Administration of  dexamethasone to pregnant rats programmes 
offspring  hypertension and increases basal corticosterone levels, 
and is associated with a reduction in hippocampal GR expres-
sion (Levitt et al., 1996). The relative lack of hippocampal GR 
would be predicted to reduce HPA axis negative feedback, leading 
to over-activity and elevation of circulating glucocorticoids (as 
depicted in Figure 2B). Such chronic mild glucocorticoid excess 
is anticipated, over time, to produce adverse metabolic, cardio-
vascular and neuropsychiatric effects, as seen in individuals with 
Cushing’s syndrome.
As well as central effects, fetal overexposure to glucocorticoids 
is also associated with alterations in the structure and function of 
numerous tissues. In terms of blood pressure regulation, prenatal 
glucocorticoid administration or maternal low protein diet leads 
to a permanent reduction in nephron number, hypersensitivity to 
the effects of vasoconstrictors and increased local GR expression in 
kidney tissue (Bertram et al., 2001). The effects of maternal low pro-
tein diet on kidney development have been proposed to act through 
increased fetal glucocorticoid exposure, secondary to an increase in 
transplacental passage of maternal glucocorticoids (Langley-Evans 
et al., 1996). As discussed previously, altered placental function is 
thought to be key in the programming of offspring phenotype.
EPIDEMIOLOGICAL EVIDENCE FOR PRENATAL 
PROGRAMMING BY EARLY LIFE STRESS
So, exposure of the feto-placental unit to excess exogenous or 
endogenous glucocorticoids can have permanent effects on the 
offspring, but does maternal stress per se exert suffi cient effect 
FIGURE 2 | Hypothalamic–pituitary–adrenal (HPA) axis: programming by early 
life stress. Under conditions of stress, sustained activation of the HPA axis is 
attenuated via negative feedback actions of circulating glucocorticoids. At least a 
component of this attenuation occurs through activation of hippocampal 
glucocorticoid receptors (GR), as shown in (A) above. Individuals exposed to stress 
during early development and/or excess glucocorticoids have reduced expression 
of GR in the hippocampus (B) leading to a loss of this feedback inhibition and an 
overactive HPA axis, both in the basal state and under conditions of stress.
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to impact the fetus in a similar way, especially as physiological 
 glucocorticoids are substrates for inactivation by placental 11β-
HSD2? In a number of human studies, prenatal stress has been 
associated with low birth weight, increased risk of premature 
delivery and impaired neurodevelopment in early life (Talge 
et al., 2007). Self-reported anxiety during pregnancy in a large 
cohort of women in the UK is associated with increased salivary 
cortisol levels in offspring at 10 years of age (O’Connor et al., 
2005). A common behavioural outcome of pregnancies affected 
by prenatal stress is an increased incidence of attention defi cit 
hyperactivity disorder (ADHD; O’Connor et al., 2002; van den 
Bergh et al., 2006). These fi ndings in humans are also supported 
by non-human primate studies, where maternal prenatal stress is 
associated with attention defi cits in offspring (van Os and Selten, 
1998; Schneider et al., 2002).
Exposure to traumatic events during pregnancy have also 
been associated with increased rates of IUGR, HPA axis dys-
regulation as well as increased risk of certain psychiatric dis-
orders. Offspring of pregnant women who were exposed to but 
survived the September 11th 2001 attacks on the World Trade 
Center showed greater incidence of IUGR compared with con-
trol populations (Berkowitz et al., 2003). In addition, maternal 
cortisol levels were reduced in those mothers who developed 
post-traumatic stress disorder (PTSD), and intriguingly this trait 
was observed in 1-year-old offspring who were in utero during 
the event (Yehuda et al., 2005). Crucially, these associations were 
confi ned to those exposed in the third trimester, whereas the 
offspring of women developing similar PTSD but exposed earlier 
in gestation did not show HPA alterations. These fi ndings are 
partly echoed by studies of offspring of Holocaust survivors with 
PTSD who show altered cortisol levels and metabolism though 
the offspring themselves have no medical or neuropsychiatric 
illness (Yehuda, 2002). These studies lend support to the idea 
that there is transmission of perturbed HPA axis function from 
mother to fetus during gestation, although they do not rule out 
the possibility that genetic differences are mediating these trans-
generational associations.
EPIGENETIC INHERITANCE AND TRANSGENERATIONAL 
TRANSMISSION OF FETAL PROGRAMMING
A growing number of studies indicate that the effects of intrauterine 
exposures (including nutritional imbalance, hormone exposure, 
heavy metal or other toxins or endocrine disruptors) can be passed 
on to subsequent generations, without further exposure of the F
1 
generation. In order for these effects to be inherited, such exposure 
must induce either stable chromosomal alterations or involve epige-
netic modifi cation that is maintained through germ cell maturation 
(Jirtle and Skinner, 2007).
As mentioned above, offspring of females administered dex-
amethasone during the last week of pregnancy exhibit lower birth 
weight and dysregulated glucose homeostasis in adulthood, in 
association with alterations in hepatic gluconeogenic enzymes 
(Nyirenda et al., 1998). When these F
1
 animals are mated, their 
offspring (F
2
) also have lower birth weight, disrupted glucose home-
ostasis and elevated liver PEPCK in the absence of any gestational 
manipulation (Drake et al., 2005). However, the F
3 
generation is 
unaffected. This most likely refl ects a transgenerational effect as 
a result of alterations in primordial germ cell formation in the F
1 
generation. This effect seems to persist through fertilisation and 
development. It follows either the female or the male line, the lat-
ter suggesting it is stable through meiosis since the exposed fetal 
testis of the F
1
 male will not begin germ cell development until 
puberty. Presumably, the glucocorticoid exposure that these ani-
mals experienced prenatally affected both somatic and germ cell 
differentiation, leading to these exposed offspring developing the 
observed phenotype but also programming gametes and affecting 
the next generation of offspring. Again, the question of timing is 
important. In the rat, gonadal sex determination occurs around 
E12–E15, and exposures that coincide with this period are likely 
to affect gamete formation. This has been shown repeatedly to be 
the case in studies looking at the effects of administering endocrine 
disruptors during early fetal life. Administration of the antian-
drogenic agent vinclozolin to pregnant rats from E8–E15 resulted 
in increased spermatogenic apoptosis, reduced male fertility and 
increased rates of adult disease in the F
1 
offspring (Anway et al., 
2005). These defects are inherited in subsequent generations, from 
F
2
–F
4
 and further can be paternally transmitted. This is particularly 
of interest as it moves the fi eld of developmental programming to 
reconsider paternal effects, as until relatively recently it has been 
the infl uence of the maternal environment and uterine events that 
have received most attention.
CONCLUSIONS
Developmental plasticity allows the adaptation of an organism to 
environmental changes in early life, doubtless to facilitate imme-
diate survival and perhaps also to ‘predict’ the likely challenges in 
later life. As highlighted in the present review, disordered HPA axis 
function and regulation is a common outcome in most, if not all, 
models of developmental programming. It is clear that alterations 
in glucocorticoid signalling in early life can induce persistent effects 
on later phenotype and disease risk.
That glucocorticoid exposure is implicated in these program-
ming effects is perhaps intuitive – alterations in neonatal levels of 
stress hormones signal to the developing HPA axis a prediction of 
what might be encountered in adult life. It may be that the set-point 
for long-term regulation of the HPA axis, by means of altered GR 
expression, is determined by early life levels of the corresponding 
ligand. From an evolutionary perspective the phenotypic out-
comes of these exposures appear to ‘make sense’. Glucocorticoid 
or stress-exposed offspring are adapted to a relatively challenging 
life – metabolic effi ciency, earlier age of puberty, elevated blood 
pressure and heightened responses to stress will enable survival 
to reproductive age under conditions of food scarcity and preda-
tion. In contemporary humans these postnatal factors in most 
developed societies rarely pertain, and consequently the actual 
adult environment often confl icts with these adaptations. This may 
plausibly promote later disease, especially after the reproductive 
years. Whether prenatal stress in humans can induce transmissible 
alterations in cardiovascular, endocrine or behavioural traits is 
yet to be determined, but follow-up analysis of those exposed to 
in utero stressors will address these questions. Also key will be to 
determine whether there may be windows during development in 
which preventative or therapeutic interventions can reverse such 
adverse programming effects.
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